Pharmaceutical compositions of hydrophobic camptothecin derivatives
US10391056B2 · kind B2 · utility
1Cited by
9References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 2, 2012 |
| Grant date | Aug 27, 2019 |
| Priority date | — |
| Expiry date | Feb 8, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition comprising at least one hydrophobic camptothecin derivative or a pharmaceutically acceptable salt of said derivative and a polyethylene glycol (PEG) conjugated phospholipid. Also provided is a method to inhibit cancer cells in a subject in need thereof by administering the pharmaceutical composition of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.